Beating Heart Myocardial Revascularization on Extracorporeal Circulation in Patients with End-Stage Coronary Artery Disease
Cardiovascular Surgery · 2001-12 · 9 (6) · 608-614
DOI: 10.1177/096721090100900615 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Cardiovascular Surgery, online erschienen am 01.12.2001. Verfasst von E Prifti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Divisione di Cardiochirurgia, Policlinico di Careggi, Firenze, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Objectives
To evaluate in a cohort of ESCAD patients (pts) the effects of on-pump/beating-heart versus conventional CABG in terms of early and mid-term survival and morbidity and LV function improvement.
Methods
Between January 1993 and December 2000, 78 (Group I) ESCAD pts underwent on-pump/beating-heart surgery. Mean age in Group I was 66.2±6 (58–79), NYHA and CCS class were 3.2±0.6 and 3.3±0.4 respectively, Myocardial viability index 0.69±0.1 (%), LVEF (%) 24.8±4, LVEDP (mmHg) 28.1±5.8 and LVEDD(mm) 69.5±6. Group II consisted in 78 ESCAD patients undergoing conventional CABG selected in a randomized fashion from an age, sex, and LVEF corrected group of patients. Mean age in Group II was 65.7±5 (57–78). NYHA 3.1±0.7, CCS 3.4±0.8, LVEF(%) 25±5, LVEDP(mmHg) 27.9±4.4 and LVEDD(mm) 69.2±7.2.
Results
Postoperatively, 5(7.7%) patients died in Group I versus 7(11.5%) patients in Group II ( P>0.1). CPB time resulted to be in Group II patients ( P=0.001) and the mean distal anastomoses per patient was similar between groups ( P=Ns). Perioperative AMI ( P=0.039), LCOS ( P= 0.002), necessity for ultrafiltration ( P=0.018) and bleeding>1000 ml ( P=0.029) were significantly higher in Group II. None of the Group I patients underwent surgical revision for bleeding versus 8(10.3%) patients in Group II ( P=0.011). At 6 months after surgery, the LV function improved significantly in Group I patients, demonstrated by an increased LVEF = 27.2±4(%)( P=0.001), lower LVEDP = 26.4±3(mmHg)( P=0.029) and LVEDD = 67±4(mm) ( P=0.004) instead of a lower LVEDD = 66.8±6(mm)( P=0.032) versus the preoperative data in Group II. The actuarial survival at 1, 3 and 5 yr were 90, 82 and 71% in Group I and 89, 83 and 74% in Group II ( P=Ns).
Conclusion
In ESCAD patients who may poorly tolerate cardioplegic arrest, on-pump/beating-heart CABG may be an acceptable alternative associated with lower postoperative mortality and morbidity. Such a technique offers a better myocardial and renal protection associated with lower postoperative complications due to intraoperative hypoperfusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Divisione di Cardiochirurgia, Policlinico di Careggi, Firenze, Italy.
Zitieren
APA
Prifti, E., Bonacchi, M., Frati, G., Giunti, G., Proietti, P., Leacche, M., Massetti, M., Babatasi, G., & Sani, G. (2001). Beating Heart Myocardial Revascularization on Extracorporeal Circulation in Patients with End-Stage Coronary Artery Disease. Cardiovascular Surgery, 9(6), 608-614. https://doi.org/10.1177/096721090100900615
Vancouver
Prifti E, Bonacchi M, Frati G, Giunti G, Proietti P, Leacche M, et al. Beating Heart Myocardial Revascularization on Extracorporeal Circulation in Patients with End-Stage Coronary Artery Disease. Cardiovascular Surgery. 2001;9(6):608-614. doi:10.1177/096721090100900615
BibTeX
@article{Prifti2001,
author = {Prifti, E and Bonacchi, M and Frati, G and Giunti, G and Proietti, P and Leacche, M and Massetti, M and Babatasi, G and Sani, G},
title = {Beating Heart Myocardial Revascularization on Extracorporeal Circulation in Patients with End-Stage Coronary Artery Disease},
journal = {Cardiovascular Surgery},
year = {2001},
volume = {9},
number = {6},
pages = {608--614},
doi = {10.1177/096721090100900615}
}
EUVIMED